Rajeev Venkayya, former head of the vaccine unit at Takeda
February 3, 2022 09:34 AM EST
People

Ra­jeev Venkayya, Take­da’s long­time vac­cines chief, de­parts to lead a stealth pan­dem­ic-fo­cused biotech

Jason Mast

Editor

Ra­jeev Venkayya, the long­time head of Take­da’s vac­cine unit, is step­ping down to be­come CEO of a new com­pa­ny “fo­cused on com­bat­ing COVID-19 and fu­ture …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times